PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.21%
Revenue growth at 75-90% of CSIQ's 19.27%. Bill Ackman would push for innovation or market expansion to catch up.
-72.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-60.26%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-42.37%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-95.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-114.57%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-115.69%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.25%
Share change of 0.25% while CSIQ is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.08%
Slight or no buyback while CSIQ is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
17.58%
OCF growth of 17.58% while CSIQ is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
130.50%
FCF growth of 130.50% while CSIQ is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
7074.36%
10Y revenue/share CAGR at 75-90% of CSIQ's 7904.95%. Bill Ackman would press for new markets or product lines to narrow the gap.
7074.36%
5Y revenue/share CAGR at 75-90% of CSIQ's 7904.95%. Bill Ackman would encourage strategies to match competitor’s pace.
409.05%
3Y revenue/share CAGR at 75-90% of CSIQ's 511.54%. Bill Ackman would expect new product strategies to close the gap.
4274.13%
OCF/share CAGR of 4274.13% while CSIQ is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
4274.13%
OCF/share CAGR of 4274.13% while CSIQ is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
251.21%
3Y OCF/share CAGR above 1.5x CSIQ's 164.52%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
107.09%
Positive 10Y CAGR while CSIQ is negative. John Neff might see a substantial advantage in bottom-line trajectory.
107.09%
Positive 5Y CAGR while CSIQ is negative. John Neff might view this as a strong mid-term relative advantage.
-94.13%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
95.42%
3Y equity/share CAGR at 50-75% of CSIQ's 141.85%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-15.43%
Inventory is declining while CSIQ stands at 13.83%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.05%
Asset growth well under 50% of CSIQ's 9.66%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.36%
Under 50% of CSIQ's 24.17%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
9.12%
Debt growth far above CSIQ's 9.48%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
3.94%
R&D dropping or stable vs. CSIQ's 26.28%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
35.79%
SG&A declining or stable vs. CSIQ's 177.04%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.